ARTICLE | Top Story
GLFD reacquires Gliadel rights from AVE
October 24, 2000 7:00 AM UTC
Guilford (GLFD) reacquired worldwide distribution and marketing rights from Aventis (AVE) to its Gliadel Wafer carmustine implant for use as an adjunct to surgery to prolong survival in patients with ...